Sinopharm Group Co. Ltd. (FRA:X2S)
2.106
+0.021 (1.01%)
At close: Aug 15, 2025, 10:00 PM CET
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of €6.67 billion as of August 15, 2025. Its market cap has decreased by -2.76% in one year.
Market Cap
6.67B
Enterprise Value
16.28B
Revenue
73.81B
Ranking
n/a
PE Ratio
7.38
Stock Price
€2.11
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 3.53B to 6.67B, an increase of 88.80%. That is a compound annual growth rate of 4.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 6.67B | -19.35% |
Dec 31, 2024 | 8.27B | 11.84% |
Dec 29, 2023 | 7.39B | -0.53% |
Dec 30, 2022 | 7.43B | 24.49% |
Dec 31, 2021 | 5.97B | -3.83% |
Dec 31, 2020 | 6.21B | -35.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 279.10B |
Siemens Aktiengesellschaft | 181.30B |
Deutsche Telekom AG | 149.07B |
Allianz SE | 143.65B |
Siemens Energy AG | 77.30B |
Rheinmetall AG | 75.19B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.88B |
Deutsche Bank Aktiengesellschaft | 60.38B |